Sergio Peralta
- Hepatology top 2%
- Liver Disease and Transplantation 7
- Hepatitis C virus research 5
- Rheumatology top 2%
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis 4
- Hematology top 5%
- Gastroenterology top 5%
-
- Liver Disease Diagnosis and Treatment 9
- Microscopic Colitis 4
-
- Inflammatory Bowel Disease 7
-
- Helicobacter pylori-related gastroenterology studies 6
- Eosinophilic Esophagitis 4
- Co-authors
- Antonio Craxı̀Francesco CicciaG TrioloAnna GiardinaAroldo RizzoRiccardo AlessandroGiacomo De LeoAleix Prat
- Cited by
- HepatologyRheumatologyImmunology
- Journals
- Digestive and Liver Disease (4 papers)Annals of Oncology (3 papers)Arthritis & Rheumatology (2 papers)
- Partner nations
- ItalySpainPalestinian Territory
In The Last Decade
Sergio Peralta
43 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 86
- Hepatology 322
- Rheumatology 571
- Immunology 529
- Hematology 257
- Gastroenterology 113
Countries citing papers authored by Sergio Peralta
This map shows the geographic impact of Sergio Peralta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Peralta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Peralta more than expected).
Fields of papers citing papers by Sergio Peralta
This network shows the impact of papers produced by Sergio Peralta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Peralta. The network helps show where Sergio Peralta may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sergio Peralta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 0 | |
| 5 | Seroprevalence of SARS-COV-2 in multiple sclerosis patients under immunomodulatory treatment in lleida (study emCOVID-19) | 2020 | 2 |
| 6 | 2016 | 1 | |
| 7 | 2016 | 96 | |
| 8 | 2015 | 2 | |
| 9 | 2012 | 19 | |
| 10 | 2011 | 106 | |
| 11 | 2010 | 37 | |
| 12 | 2010 | 16 | |
| 13 | 2010 | 48 | |
| 14 | 2009 | 68 | |
| 15 | 2009 | 195 | |
| 16 | 2008 | 56 | |
| 17 | 2008 | 48 | |
| 18 | 2007 | 76 | |
| 19 | The effect of antiviral therapy on clinical outcome of HCV cirrhosis with portal hypertension: a prospective cohort study. | 2006 | 0 |
| 20 | 2001 | 4 |
About Sergio Peralta
Sergio Peralta is a scholar working on Hepatology, Gastroenterology, Epidemiology, Rheumatology and Dermatology, having authored 49 papers that have together received 1.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (7 papers), Inflammatory Bowel Disease (7 papers), Helicobacter pylori-related gastroenterology studies (6 papers), Hepatitis C virus research (5 papers), Eosinophilic Esophagitis (4 papers), Microscopic Colitis (4 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). The work is most often cited by research in Hepatology (322 citations), Rheumatology (571 citations), Immunology (529 citations), Hematology (257 citations) and Gastroenterology (113 citations). Sergio Peralta has collaborated with scholars based in Italy, Spain and Palestinian Territory. Frequent co-authors include Antonio Craxı̀, Francesco Ciccia, G Triolo, Anna Giardina, Aroldo Rizzo, Riccardo Alessandro, Giacomo De Leo, Aleix Prat, Giuliana Guggino and Alfonso Principato. Their work appears in journals such as Digestive and Liver Disease, Annals of Oncology, Arthritis & Rheumatology, Gastroenterology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.